HUA MEDICINE-B (02552) announced that on November 28, 2025, the company granted share options to three executive directors and 71 employees under the company's share option plan, which was conditionally approved and adopted on August 26, 2018, and became effective on September 14, 2018. The grant is subject to acceptance by the grantees. The share options entitle the grantees to subscribe for a total of 20 million new shares in the company's share capital, each with a nominal value of $0.001.